Filter posts

California Continues Responsible Support for Interchangeability of Biologic Drugs

Yesterday, California’s State Assembly Committee on Appropriations took another decisive step when they unanimously voted …

Fresenius v. Baxter: BIO files Amicus Brief in Federal Circuit

The Biotechnology Industry Organization filed an amicus brief at the Federal Circuit in the case …

TTIP: Global Regulatory Cooperation and Convergence

The Transatlantic Trade and Investment Partnership (TTIP) initiative holds tremendous promise for the long-term competitiveness …

Bayh-Dole and Technology Transfer Continue to Deliver

The Association of University Technology Managers released the 2012 AUTM U.S. Licensing Activity Survey Highlights …

TPP and Innovation in the Bioeconomy: The Need for 12 Years of Data Protection

A few weeks ago, BIO submitted a letter and white paper (PDF) to the U.S. Trade Representative outlining recommendations …

NORD Urges Congress: Don’t Cut Orphan Drug Tax Credit

This week, the National Organization of Rare Disorders (NORD) and more than 70 patient organizations …

Patent Docs Highlights the BIO IPDx Symposium

Patent Docs recently highlighted McDonnell Boehnen Hulbert & Berghoff’s (MBHB) panel at BIO’s IP and …

BioOhio Selects New Leadership

John Lewis has been promoted to CEO of BioOhio, the biological sciences trade organization, recognized …

The Hill: Innovation-focused tax reform for U.S. global competitiveness

The Hill Blog published an op-ed by Geoff Davis on ‘Innovation-focused tax reform for U.S. …

BIO IP & Diagnostics Symposium

BIO’s IP & Diagnostics Symposium (BIO IPDX) will review the current patent law landscape and …